Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implications Shazia SofiUmar MehrajManzoor A. Mir Review Article 29 April 2022 Article: 106
Telomerase gene therapy: a remission toward cancer Sameer Quazi Review Article 16 April 2022 Article: 105
Should routine risk reduction procedures for the prevention and control of pandemics become a standard in all oncological outpatient clinics? The prospective COVID-19 cohort study: protect-CoV Theres FeyNicole EricksonVolker Heinemann Original Paper Open access 10 April 2022 Article: 104
Chidamide augment sorafenib-derived anti-tumor activities in human osteosarcoma cells lines and xenograft mouse model Ying YuanDaifeng LiAixi Yu Original Paper 28 April 2022 Article: 87
Unique combinations of epigenetic modifiers synergistically impair the viability of the U87 glioblastoma cell line while exhibiting minor or moderate effects on normal stem cell growth Arshak R. AlexanianAvonlea Brannon Short Communication 28 April 2022 Article: 86
Photodynamic therapy using mannose-conjugated chlorin e6 increases cell surface calreticulin in cancer cells and promotes macrophage phagocytosis Yuka KimuraHiromasa AokiMineyoshi Aoyama Short Communication 28 April 2022 Article: 82
Optimized flow cytometric detection of transient receptor potential vanilloid-1 (TRPV1) in human hematological malignancies Sofia A. OmariDominic P. GeraghtyMurray J. Adams Original Paper Open access 28 April 2022 Article: 81
ENO3 promotes colorectal cancer progression by enhancing cell glycolysis Jingyu ChenZizhen ZhangMeng Xue Original Paper 28 April 2022 Article: 80
KRT15 promotes colorectal cancer cell migration and invasion through β-catenin/MMP-7 signaling pathway Weida ChenChengli Miao Original Paper 28 April 2022 Article: 68
Controversy of tissue-agnostic approvals in immunotherapy and targeted therapy Chinmoy K. Bose Short Communication 28 April 2022 Article: 67
Effects of an enteral nutrient-rich therapy with omega-3 fatty acids in patients with unresectable or recurrent biliary tract cancer or pancreatic cancer during chemotherapy: a case–control study Kyohei AbeTadashi UwagawaToru Ikegami Original Paper Open access 28 April 2022 Article: 66
Mutation in SF3B1 gene promotes formation of polyploid giant cells in Leukemia cells Sanjay MukherjeeAbdullah Mahmood AliAzra Raza Original Paper Open access 28 April 2022 Article: 65
ERBB2 S310F mutation independently activates PI3K/AKT and MAPK pathways through homodimers to contribute gallbladder carcinoma growth Kun FanJiwen WangHoubao Liu Original Paper 28 April 2022 Article: 64
Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer Diane K. ReyesBruce J. TrockKenneth J. Pienta Original Paper 28 April 2022 Article: 63
The role of miR-153 and related upstream/downstream pathways in cancers: from a potential biomarker to treatment of tumor resistance and a therapeutic target Vahab Alamdari-PalangiKhojaste Rahimi JaberiAmir Savardashtaki Review Article 28 April 2022 Article: 62
Inhibition of DDX3 and COX-2 by forskolin and evaluation of anti-proliferative, pro-apoptotic effects on cervical cancer cells: molecular modelling and in vitro approaches Doneti RavinderShailima RampoguSmita C. Pawar Original Paper 28 April 2022 Article: 61
Evidence of a role for interleukin-6 in anoikis resistance in oral squamous cell carcinoma Marilena KaravyrakiRichard K. Porter Original Paper Open access 29 April 2022 Article: 60
